
You can purchase shares of ADAPTIMMUNE THERAPTCS ADR by Adaptimmune Therapeutics plc (OTCPK:ADAPY) through any online brokerage.
There are no as such competitors for ADAPTIMMUNE THERAPTCS ADR by Adaptimmune Therapeutics plc.
There is no analysis for ADAPTIMMUNE THERAPTCS ADR by Adaptimmune Therapeutics plc to provide a consensus price target.
The stock price for ADAPTIMMUNE THERAPTCS ADR by Adaptimmune Therapeutics plc (OTCPK: ADAPY) is $ last updated .
There are no upcoming dividends for ADAPTIMMUNE THERAPTCS ADR by Adaptimmune Therapeutics plc.
ADAPTIMMUNE THERAPTCS ADR by Adaptimmune Therapeutics plc does not have any upcoming earnings scheduled.
There is no upcoming split for ADAPTIMMUNE THERAPTCS ADR by Adaptimmune Therapeutics plc.
ADAPTIMMUNE THERAPTCS ADR by Adaptimmune Therapeutics plc is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.
Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer...